home / stock / vnda / vnda quote
Last: | $4.535 |
---|---|
Change Percent: | -0.55% |
Open: | $4.55 |
Close: | $4.56 |
High: | $4.57 |
Low: | $4.46 |
Volume: | 223,447 |
Last Trade Date Time: | 04/25/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.535 | $4.55 | $4.56 | $4.57 | $4.46 | 223,447 | 04-25-2024 |
$4.56 | $4.63 | $4.56 | $4.67 | $4.5508 | 1,183,979 | 04-24-2024 |
$4.63 | $4.76 | $4.63 | $4.87 | $4.62 | 1,370,689 | 04-23-2024 |
$4.8 | $5.1 | $4.8 | $5.12 | $4.785 | 2,114,924 | 04-22-2024 |
$5.11 | $4.94 | $5.11 | $5.3 | $4.93 | 2,440,757 | 04-19-2024 |
$4.97 | $5.16 | $4.97 | $5.245 | $4.89 | 3,859,528 | 04-18-2024 |
$5.24 | $5.42 | $5.24 | $5.67 | $4.99 | 24,035,651 | 04-17-2024 |
$4.05 | $4.02 | $4.05 | $4.08 | $3.985 | 790,418 | 04-16-2024 |
$4.06 | $4.12 | $4.06 | $4.16 | $4.01 | 787,157 | 04-15-2024 |
$4.12 | $4.27 | $4.12 | $4.3 | $4.08 | 762,864 | 04-12-2024 |
$4.28 | $4.3 | $4.28 | $4.32 | $4.18 | 766,830 | 04-11-2024 |
$4.28 | $4.3 | $4.28 | $4.37 | $4.14 | 1,158,986 | 04-10-2024 |
$4.36 | $4.49 | $4.36 | $4.68 | $4.34 | 1,795,024 | 04-09-2024 |
$4.51 | $4.83 | $4.51 | $4.83 | $4.49 | 1,690,131 | 04-08-2024 |
$4.82 | $4.97 | $4.82 | $4.99 | $4.79 | 1,669,599 | 04-05-2024 |
$4.92 | $5.14 | $4.92 | $5.44 | $4.84 | 6,158,464 | 04-04-2024 |
$5.05 | $4.65 | $5.05 | $6.03 | $4.37 | 50,710,619 | 04-03-2024 |
$3.91 | $4.02 | $3.91 | $4.0201 | $3.87 | 2,122,933 | 04-02-2024 |
$4.12 | $4.23 | $4.12 | $4.24 | $4.085 | 735,827 | 04-01-2024 |
$4.11 | $3.92 | $4.11 | $4.19 | $3.91 | 1,372,202 | 03-29-2024 |
News, Short Squeeze, Breakout and More Instantly...
Vanda Pharmaceuticals Inc. Company Name:
VNDA Stock Symbol:
NASDAQ Market:
Vanda Pharmaceuticals Inc. Website:
Reminds Vanda’s Board of Their Fiduciary Duties Given the Mishandling of Future Pak’s Offer to Acquire Vanda’s Underperforming and Undervalued Shares at an ~80-90% Premium Expresses Serious Concerns Over Entrenchment, Misaligned Incentives, and Cronyism at Vanda, Incl...
Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation PR Newswire WASHINGTON , April 22, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the Supreme Court denied Va...
The U.S. Supreme Court has reportedly chosen not to review Vanda Pharmaceuticals Inc’s (NASDAQ:VNDA) attempt to revive patents...